| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Copine-3 is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
CPNE3 |
| Gene ID: |
8895 |
| Uniprot ID: |
CPNE3_HUMAN |
| Specificity: |
This antibody detects endogenous levels of CPNE3 at Human, Mouse |
| Immunogen: |
Synthesized peptide derived from human CPNE3 |
| Post Translational Modifications | Phosphorylated on serine and threonine residues. |
| Function | Calcium-dependent phospholipid-binding protein that plays a role in ERBB2-mediated tumor cell migration in response to growth factor heregulin stimulation. |
| Protein Name | Copine-3Copine Iii |
| Database Links | Reactome: R-HSA-1483206Reactome: R-HSA-6798695 |
| Cellular Localisation | NucleusCytoplasmCell MembraneCell JunctionFocal AdhesionAssociates To The Membrane In A Calcium-Dependent MannerTranslocates To The Cell Membrane And The Nucleus In A Calcium- Or Growth Factor Heregulin-Dependent MannerColocalizes With The Tyrosine Phosphorylated Erbb2 Form At Cell Membrane And Focal Adhesions In A Calcium- Or Growth Factor Heregulin-Dependent Manner |
| Alternative Antibody Names | Anti-Copine-3 antibodyAnti-Copine Iii antibodyAnti-CPNE3 antibodyAnti-CPN3 antibodyAnti-KIAA0636 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
